NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  European Journal of Pharmacology

• Publication date

  2000-11-10

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0014-2999(00)00709-3PMID 11070180
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior

  2005cited by this paper
• Effect of NMDA- and strychnine-insensitive glycine site antagonists on NMDA-mediated convulsions and learning

  2005cited by this paper
• Glutamate: its role in learning, memory, and the aging brain

  2005cited by this paper
• Ligands of the NMDA receptor-associated glycine recognition site and motor behavior

  2005cited by this paper
• Glycine site antagonists abolish dopamine D 2 but not D 1 receptor mediated catalepsy in rats

  2005cited by this paper
• Is pharmacological neuroprotection dependent on reduced glutamate release?

  2000cited by this paper
• Neuroprotective effects of riluzole: An electrophysiological and histological analysis in an in vitro model of ischemia

  1999cited by this paper
• Riluzole series. Synthesis and in vivo "antiglutamate" activity of 6-substituted-2-benzothiazolamines and 3-substituted-2-imino-benzothiazolines.

  1999cited by this paper
• Riluzole, a glutamate release inhibitor, and motor behavior

  1998cited by this paper
• Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons.

  1998cited by this paper
• Effects of depolarizing stimuli on calcium homeostasis in cultured rat motoneurones

  1998cited by this paper
• Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons.

  1998cited by this paper
• Effects of riluzole on rat cortical neurones: an in vitro electrophysiological study

  1997cited by this paper
• Riluzole Blocks Dopamine Release Evoked by N‐methyl‐D‐aspartate, Kainate, and Veratridine in the Rat Striatum

  1997cited by this paper
• The Riluzole Early Access Programme: descriptive analysis of 844 patients in France. ALS/Riluzole Study Group III.

  1997cited by this paper
• A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices

  1996cited by this paper
• Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.

  1996cited by this paper
• Amyotrophic lateral sclerosis: current and future treatment strategies.

  1996cited by this paper
• Behavioral effects mediated by the modulatory glycine site of the NMDA receptor in the anterodorsal striatum and nucleus accumbens

  1996cited by this paper
• ALS therapy

  1996cited by this paper
• The pharmacology and mechanism of action of riluzole

  1996cited by this paper
• Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice.

  1996cited by this paper
• Dose-ranging study of riluzole in amyotrophic lateral sclerosis

  1996cited by this paper
• Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures.

  1995cited by this paper
• Effect of riluzole on quinolinate-induced neuronal damage in rats: comparison with blockers of glutamatergic neurotransmission.

  1995cited by this paper
• A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group.

  1994cited by this paper
• Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.

  1994cited by this paper
• Glutamate antagonists have different effects on spontaneous locomotor activity in rats.

  1994cited by this paper
• Fenbufen Pretreatment Potentiates the Anticonvulsant Activity of CPPene and NBQX in DBA/2 Mice

  1994cited by this paper
• Neuroprotective effects of riluzole in ALS CSF toxicity.

  1994cited by this paper
• Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole.

  1994cited by this paper
• Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines.

  1993cited by this paper
• The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1.

  1993cited by this paper
• Anticonvulsant effects of U-54494A and U-50488H in genetically epilepsy-prone rats and DBA/2 mice: a possible involvement of glycine/NMDA receptor complex.

  1993cited by this paper
• Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats.

  1993cited by this paper
• Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.

  1993cited by this paper
• The NMDA receptor, NMDA antagonists and epilepsy therapy. A status report.

  1992cited by this paper
• Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.

  1992cited by this paper
• Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia.

  1992cited by this paper
• Anticonvulsant and sleep-waking influences of riluzole in a rat model of absence epilepsy.

  1991cited by this paper
• Glycine potentiation of anticonvulsant drugs in pentylenetetrazol seizures in rats.

  1991cited by this paper
• Anticonvulsant drug potentiation by glycine in maximal electroshock seizures is mimicked by D-serine and antagonized by 7-chlorokynurenic acid.

  1991cited by this paper
• Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre

  1991cited by this paper
• Modulation of seizure susceptibility in the mouse by the strychnine‐insensitive glycine recognition site of the NMDA receptor/ion channel complex

  1990cited by this paper
• Potentiation by glycine of anticonvulsant drugs in maximal electroshock seizures in rats.

  1990cited by this paper
• Excitatory amino acid neurotoxicity and neurodegenerative disease.

  1990cited by this paper
• Characterization df a [3H]Glycine Recognition Site as a Modulatory Site of the N‐Methyl‐D‐Aspartate Receptor Complex

  1989cited by this paper
• Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils

  1989cited by this paper
• Ibotenic acid stimulates D-[3H]aspartate release from cultured cerebellar granule cells.

  1989cited by this paper
• Anticonvulsant effects of some calcium entry blockers in DBA/2 mice

  1988cited by this paper
• Glycine potentiates strychnine-induced convulsions: role of NMDA receptors

  1988cited by this paper
• Seizure Susceptibility in DBA and C57 Mice: The Effects of Various Convulsants

  1988cited by this paper
• Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists.

  1988cited by this paper
• Glycine potentiates the NMDA response in cultured mouse brain neurons

  1987cited by this paper
• Glycine potentiates the anticonvulsant action of diazepam and phenobarbital in kindled amygdaloid seizures of rats.

  1986cited by this paper
• 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.

  1985cited by this paper
• A Review of Mouse Mutants as Genetic Models of Epilepsy

  1985cited by this paper
• Glycine potentiates the action of some anticonvulsant drugs in some seizure models

  1984cited by this paper
• Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures.

  1984cited by this paper
• Anticonvulsant actions of DS 103-282. Pharmacological studies in rodents and the baboon, Papio papio.

  1984cited by this paper
• Synergistic anticonvulsant effects of GABA-T inhibitors and glycine

  1984cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Riluzole attenuates acute neural injury and reactive gliosis, hippocampal-dependent cognitive impairments and spontaneous recurrent generalized seizures in a rat model of temporal lobe epilepsy

  2024cites this paper
• Audiogenic epileptic DBA/2 mice strain as a model of genetic reflex seizures and SUDEP

  2023cites this paper
• Cenobamate enhances the anticonvulsant effect of other antiseizure medications in the DBA/2 mouse model of reflex epilepsy.

  2023cites this paper
• An In Vivo Electroencephalographic Analysis of the Effect of Riluzole against Limbic and Absence Seizure and Comparison with Glutamate Antagonists

  2023influential citation
• Variant-specific changes in persistent or resurgent sodium current in SCN8A-related epilepsy patient-derived neurons.

  2020cites this paper
• Variant-specific changes in persistent or resurgent Na+ current in SCN8A-EIEE13 iPSC-derived neurons

  2020cites this paper
• Riluzole Attenuates L-DOPA-Induced Abnormal Involuntary Movements Through Decreasing CREB1 Activity: Insights from a Rat Model

  2018cites this paper
• Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis

  2018cites this paper
• Methylcobalamin prevents mutant superoxide dismutase-1-induced motor neuron death in vitro

  2017cites this paper
• Genetically epilepsy-prone rats (GEPRs) and DBA/2 mice: Two animal models of audiogenic reflex epilepsy for the evaluation of new generation AEDs.

  2017cites this paper
• The role of group I metabotropic glutamate receptors in absence epilepsy

  2016cites this paper
• Anticonvulsant potential of certain N-(6-substituted benzo[d] thiazol-2-yl)-2-(4-substituted piperazin-1-yl)acetamides

  2016cites this paper
• The effect of riluzole alone and in combination with sodium valproate on pentylenetetrazole induced seizures in swiss-albino rats

  2016cites this paper
• Anticonvulsant effects of structurally diverse GABA(B) positive allosteric modulators in the DBA/2J audiogenic seizure test: Comparison to baclofen and utility as a pharmacodynamic screening model.

  2016cites this paper
• Are big potassium-type Ca2+-activated potassium channels a viable target for the treatment of epilepsy?

  2015cites this paper
• Synthesis and biological evaluation of new 2-amino-6-(trifluoromethoxy)benzoxazole derivatives, analogues of riluzole

  2013cites this paper
• Delayed amnesic syndrome after riluzole use in major depressive disorder: a case report.

  2013cites this paper
• Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial

  2013cites this paper
• Riluzole increases the rate of glucose transport in L6 myotubes and NSC-34 motor neuron-like cells via AMPK pathway activation

  2013cites this paper
• Riluzole and gabapentinoids activate glutamate transporters to facilitate glutamate-induced glutamate release from cultured astrocytes.

  2012cites this paper
• The Protective Effects of Riluzole on Manganese-Induced Disruption of Glutamate Transporters and Glutamine Synthetase in the Cultured Astrocytes

  2012cites this paper
• Discovery of potent anticonvulsant ligands as dual NMDA and AMPA receptors antagonists by molecular modelling studies

  2012cites this paper
• Riluzole Treatment Reduces Motoneuron Death Induced by Axotomy in Newborn Rats

  2012cites this paper
• Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis.

  2012cites this paper
• The NMDA receptor complex as a therapeutic target in epilepsy: a review.

  2011cites this paper
• Developing novel therapeutics for excitotoxic neuronal death following stroke

  2011cites this paper
• The role of Rab5a GTPase in endocytosis and post-endocytic trafficking of the hCG-human luteinizing hormone receptor complex

  2011cites this paper
• Activation of glutamate transporters in the locus coeruleus paradoxically activates descending inhibition in rats.

  2010cites this paper
• Central Administration of Minocycline and Riluzole Prevents Morphine-Induced Tolerance in Rats

  2009cites this paper
• Neurotransmitter evaluation in the hippocampus of rats after intracerebral injection of TsTX scorpion toxin

  2009cites this paper
• iluzole protects against glutamate-induced slowing of neurofilament xonal transport

  2009cites this paper
• Direct effects of riluzole on 5-hydroxytryptamine (5-HT)3 receptor-activated ion currents in NCB-20 neuroblastoma cells.

  2008cites this paper
• 5,7 Dichlorokynurenic Acid

  2008cites this paper
• Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells.

  2008cites this paper
• Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1.

  2008cites this paper
• Riluzole in the Treatment of Mood and Anxiety Disorders

  2008cites this paper
• NMDA Receptor Subunits Have Differential Roles in Mediating Excitotoxic Neuronal Death Both In Vitro and In Vivo

  2007cites this paper
• Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder.

  2006cites this paper
• Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data

  2005cites this paper
• Involvement of Scn1b and Kcna1 ion channels in audiogenic seizures and PTZ-induced epilepsy.

  2005cites this paper
• Glutamate modulators as novel interventions for mood disorders.

  2005cites this paper
• An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression.

  2005cites this paper
• Investigation of the mechanisms of action of the anticonvulsant topiramate : electrophysiological studies on rat olfactory cortical neurones in vitro and some in vivo rodent models of epilepsy.

  2005cites this paper
• Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology

  2004cites this paper
• Interactions between riluzole and conventional antiepileptic drugs – a comparison of results obtained in the subthreshold method and isobolographic analysis

  2004influential citation
• Riluzole enhances the anti-seizure action of conventional antiepileptic drugs against pentetrazole-induced convulsions in mice.

  2004cites this paper
• An open-label trial of riluzole in patients with treatment-resistant major depression.

  2004cites this paper
• Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions.

  2003cites this paper
• Riluzole inhibits spontaneous Ca2+ signaling in neuroendocrine cells by activation of K+ channels and inhibition of Na+ channels

  2003cites this paper
• Glutamate and blood pressure in multiple system atrophy

  2003cites this paper
• Regulation of Cellular Plasticity Cascades in the Pathophysiology and Treatment of Mood Disorders

  2003cites this paper
• Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.

  2003cites this paper
• Glutamate and blood pressure in multiple system atrophy

  2003cites this paper
• Kainate‐induced currents in rat cortical neurons in culture are modulated by riluzole

  2002cites this paper
• The crude extract from the sea anemone, Bunodosoma caissarum elicits convulsions in mice: possible involvement of the glutamatergic system.

  2002cites this paper